VIVUS, Inc. (VVUS) Announces Pricing of Offering of $220 Million of 4.50% Convertible Senior Notes
5/16/2013 9:41:35 AM
More...
|
VIVUS, Inc. (VVUS) Announces Proposed Offering of Convertible Senior Notes
5/15/2013 9:16:21 AM
More...
|
VIVUS, Inc. (VVUS) Announces Scientific Presentations
5/14/2013 9:12:58 AM
More...
|
VIVUS, Inc. (VVUS) Appoints J. Martin Carroll and Jorge Plutzky, M.D. to Board of Directors
5/13/2013 9:31:43 AM
More...
|
Obesity Battle Heats Up as VIVUS, Inc. (VVUS) Talks to Partners
5/9/2013 8:15:39 AM
More...
|
VIVUS, Inc. (VVUS) Reports First Quarter 2013 Financial Results
5/8/2013 9:27:20 AM
More...
|
VIVUS, Inc. (VVUS) Announces Richard Fante, Former President U.S. and CEO North America, AstraZeneca PLC (AZN), to Serve as Senior Advisor
5/7/2013 9:34:15 AM
More...
|
VIVUS, Inc. (VVUS) Release: New Guidelines From American Association of Clinical Endocrinologists Recommend Medical Treatment of Obesity
5/1/2013 1:16:06 PM
More...
|
VIVUS, Inc. (VVUS) Appoints Robert N. Wilson to Board of Directors
4/30/2013 11:50:04 AM
More...
|
VIVUS, Inc. (VVUS) Announces Positive Recommendation From CHMP Supporting Avanafil Approval in Europe
4/26/2013 11:01:14 AM
More...
|
|